Arginine methyltransferase inhibitors and uses thereof
US9732041B2 · kind B2 · utility
17Cited by
37References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 7, 2016 |
| Grant date | Aug 15, 2017 |
| Priority date | — |
| Expiry date | Apr 7, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting arginine methyltransferase activity. Methods of using the compounds for treating arginine methyltransferase-mediated disorders are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.